TARA

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Protara Therapeutics Inc

NASDAQ | TARA

5.09

USD

$0.00

(

0.00%

)

At Close (As of Oct 24, 2025)

$199.08M

Market Cap

-

P/E Ratio

-1.56

EPS

$6.88

52 Week High

$2.21

52 Week Low

HEALTHCARE

Sector

TARA Chart

Recent Chart
Price Action

TARA Technicals

Tags:

TARA Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$332K
Total Revenue $0
Cost Of Revenue $332K
Costof Goods And Services Sold $332K
Operating Income -$49M
Selling General And Administrative $17M
Research And Development $32M
Operating Expenses $49M
Investment Income Net -
Net Interest Income $4.1M
Interest Income $4.1M
Interest Expense $4.2M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -$8.7M
Income Before Tax -$45M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$45M
Comprehensive Income Net Of Tax -
Ebit -$40M
Ebitda -$49M
Net Income -$45M

Revenue & Profitability

Earnings Performance

TARA Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $181M
Total Current Assets $172M
Cash And Cash Equivalents At Carrying Value $163M
Cash And Short Term Investments $163M
Inventory -
Current Net Receivables -
Total Non Current Assets $9.3M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $3.2M
Intangible Assets Excluding Goodwill $3.2M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $7.5M
Other Current Assets $1.9M
Other Non Current Assets -
Total Liabilities $14M
Total Current Liabilities $11M
Current Accounts Payable $4.4M
Deferred Revenue -
Current Debt -
Short Term Debt $2.2M
Total Non Current Liabilities $3.4M
Capital Lease Obligations $4.5M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $4.5M
Other Current Liabilities $4.3M
Other Non Current Liabilities -
Total Shareholder Equity $167M
Treasury Stock -
Retained Earnings -$245M
Common Stock $35K
Common Stock Shares Outstanding $21M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$36M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $332K
Capital Expenditures $63K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $19M
Cashflow From Financing $140M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$45M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$332K
Total Revenue $0
Cost Of Revenue $332K
Costof Goods And Services Sold $332K
Operating Income -$49M
Selling General And Administrative $17M
Research And Development $32M
Operating Expenses $49M
Investment Income Net -
Net Interest Income $4.1M
Interest Income $4.1M
Interest Expense $4.2M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -$8.7M
Income Before Tax -$45M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$45M
Comprehensive Income Net Of Tax -
Ebit -$40M
Ebitda -$49M
Net Income -$45M

TARA News

TARA Profile

Protara Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Protara Therapeutics, Inc. (TARA) is a clinical-stage biopharmaceutical company headquartered in New York, dedicated to developing innovative therapies for cancer and rare diseases. The company's proprietary product candidates utilize advanced drug delivery technologies designed to improve therapeutic outcomes for patients with significant unmet medical needs. With a strong pipeline supported by strategic collaborations, Protara is well-positioned to advance transformative treatments while prioritizing the enhancement of shareholder value.

BYND
-23.06%
$2.18
WGRX
+185.43%
$1.14
TOVX
+1.63%
$0.34
YYAI
-14.98%
$0.07
VIVK
+11.91%
$0.29
F
+12.07%
$13.83
INTC
+0.31%
$38.28
YDKG
-15.04%
$0.06
BURU
+15.68%
$0.39
CGBS
-39.47%
$0.03
CENN
-5.04%
$0.20
DVLT
+43.15%
$3.22
VHAI
0.00%
$0.00
ASST
+27.28%
$1.10
NVDA
+2.25%
$186.26
BITF
+10.68%
$4.61
ADAP
-3.44%
$0.07
AAL
+7.90%
$13.78
MSAI
+101.73%
$1.35
TSLA
-3.39%
$433.72
RGTI
-1.90%
$38.84
NEUP
+54.07%
$6.24
CJET
+27.98%
$0.11
T
+2.21%
$25.16
PLUG
+2.43%
$2.95
DNN
+2.56%
$2.80
NOK
+1.94%
$6.29
SCNX
-39.61%
$1.57
RIG
+0.77%
$3.92
AMD
+7.63%
$252.92
AXDX
-61.36%
$0.03
ABEV
-1.13%
$2.18
QBTS
+5.15%
$32.65
RF
+1.95%
$24.57
SMCI
-8.72%
$47.92
LAES
+22.55%
$7.01
GRAB
+1.77%
$5.72
QLGN
+3.11%
$3.64
ONDS
+5.66%
$7.46
NUAI
+48.35%
$5.86
TLRY
+0.67%
$1.49
QS
+14.73%
$16.82
SOFI
+3.93%
$29.18
CAN
+7.38%
$1.89
JOBY
+1.29%
$15.67
WTO
-7.14%
$0.06
AIRE
-22.42%
$0.76
ETHD
-3.40%
$3.83
ACHR
+3.52%
$11.29
RMBL
+60.50%
$3.21
IONZ
-3.76%
$3.83
RXRX
+5.41%
$6.04
ADD
-25.47%
$0.05
NIO
+0.21%
$6.90
VLY
+4.24%
$10.56
QUBT
-2.57%
$15.53
IREN
+12.60%
$62.90
GPUS
-0.28%
$0.38
RR
+12.17%
$6.08
AMC
-1.64%
$2.68
SRM
+53.27%
$10.30
CIFR
+7.10%
$17.25
NVTS
+3.37%
$14.07
PLTR
+2.29%
$184.63
BTBT
+4.97%
$3.90
UUUU
+0.47%
$21.36
BTG
-0.47%
$5.20
AAPL
+0.43%
$259.58
AMZN
+1.53%
$224.48
DFLI
+14.15%
$1.29
BBD
+0.14%
$3.35
MARA
+1.66%
$19.54
RVPH
+18.99%
$0.67
CUTR
-10.19%
$0.09
APLD
+0.14%
$33.43
PBR
-0.84%
$11.74
NAKA
+5.66%
$0.84
WU
+10.13%
$8.96
WLGS
-5.57%
$0.04
SOUN
-1.42%
$17.98
VZ
+1.14%
$38.84
ETWO
0.00%
$3.30
SNAP
+1.28%
$7.87
RGTZ
+3.08%
$15.36
MU
+5.95%
$219.02
RIVN
-0.67%
$13.00
WBD
-0.47%
$21.15
LUMN
+3.78%
$8.08
HOOD
+4.06%
$139.79
SMR
+0.37%
$37.70
IVZ
+1.43%
$23.00
AFMD
-34.94%
$0.18
ERIC
-0.31%
$9.44
IONQ
+1.94%
$60.52
KDLY
+10.41%
$0.79
EONR
-15.10%
$0.53
PFE
+0.44%
$24.78
BAC
+1.55%
$52.56
WULF
+5.67%
$13.61
EOSE
+11.83%
$16.05
BYND
-23.06%
$2.18
WGRX
+185.43%
$1.14
TOVX
+1.63%
$0.34
YYAI
-14.98%
$0.07
VIVK
+11.91%
$0.29
F
+12.07%
$13.83
INTC
+0.31%
$38.28
YDKG
-15.04%
$0.06
BURU
+15.68%
$0.39
CGBS
-39.47%
$0.03
CENN
-5.04%
$0.20
DVLT
+43.15%
$3.22
VHAI
0.00%
$0.00
ASST
+27.28%
$1.10
NVDA
+2.25%
$186.26
BITF
+10.68%
$4.61
ADAP
-3.44%
$0.07
AAL
+7.90%
$13.78
MSAI
+101.73%
$1.35
TSLA
-3.39%
$433.72
RGTI
-1.90%
$38.84
NEUP
+54.07%
$6.24
CJET
+27.98%
$0.11
T
+2.21%
$25.16
PLUG
+2.43%
$2.95
DNN
+2.56%
$2.80
NOK
+1.94%
$6.29
SCNX
-39.61%
$1.57
RIG
+0.77%
$3.92
AMD
+7.63%
$252.92
AXDX
-61.36%
$0.03
ABEV
-1.13%
$2.18
QBTS
+5.15%
$32.65
RF
+1.95%
$24.57
SMCI
-8.72%
$47.92
LAES
+22.55%
$7.01
GRAB
+1.77%
$5.72
QLGN
+3.11%
$3.64
ONDS
+5.66%
$7.46
NUAI
+48.35%
$5.86
TLRY
+0.67%
$1.49
QS
+14.73%
$16.82
SOFI
+3.93%
$29.18
CAN
+7.38%
$1.89
JOBY
+1.29%
$15.67
WTO
-7.14%
$0.06
AIRE
-22.42%
$0.76
ETHD
-3.40%
$3.83
ACHR
+3.52%
$11.29
RMBL
+60.50%
$3.21
IONZ
-3.76%
$3.83
RXRX
+5.41%
$6.04
ADD
-25.47%
$0.05
NIO
+0.21%
$6.90
VLY
+4.24%
$10.56
QUBT
-2.57%
$15.53
IREN
+12.60%
$62.90
GPUS
-0.28%
$0.38
RR
+12.17%
$6.08
AMC
-1.64%
$2.68
SRM
+53.27%
$10.30
CIFR
+7.10%
$17.25
NVTS
+3.37%
$14.07
PLTR
+2.29%
$184.63
BTBT
+4.97%
$3.90
UUUU
+0.47%
$21.36
BTG
-0.47%
$5.20
AAPL
+0.43%
$259.58
AMZN
+1.53%
$224.48
DFLI
+14.15%
$1.29
BBD
+0.14%
$3.35
MARA
+1.66%
$19.54
RVPH
+18.99%
$0.67
CUTR
-10.19%
$0.09
APLD
+0.14%
$33.43
PBR
-0.84%
$11.74
NAKA
+5.66%
$0.84
WU
+10.13%
$8.96
WLGS
-5.57%
$0.04
SOUN
-1.42%
$17.98
VZ
+1.14%
$38.84
ETWO
0.00%
$3.30
SNAP
+1.28%
$7.87
RGTZ
+3.08%
$15.36
MU
+5.95%
$219.02
RIVN
-0.67%
$13.00
WBD
-0.47%
$21.15
LUMN
+3.78%
$8.08
HOOD
+4.06%
$139.79
SMR
+0.37%
$37.70
IVZ
+1.43%
$23.00
AFMD
-34.94%
$0.18
ERIC
-0.31%
$9.44
IONQ
+1.94%
$60.52
KDLY
+10.41%
$0.79
EONR
-15.10%
$0.53
PFE
+0.44%
$24.78
BAC
+1.55%
$52.56
WULF
+5.67%
$13.61
EOSE
+11.83%
$16.05
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.